Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN)a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections.

Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN) started its trading session with the price of $ 9.11 and closed at $ 9.03 by scoring  -0.77% and traded with total volume of 1.76M shares, while the average trading remained 4.23M shares. During last trade its minimum price was $9.00 and it gained the highest price of $9.20. Its market capitalization was $1.07B.

MRC Global Inc(NYSE:MRC)has closed the formerly declared offering of Series A Convertible Perpetual Preferred Stock to an associate of Cornell Capital LLC for $363 million.  The Company anticipates to use the net proceeds to pay down its term loan and asset based lending facility.

MRC Global Inc(NYSE:MRC) showing dropped of -3.00% and closed at $ 15.53, after gaining total volume of 1.72M shares. Its opening price was $ 15.94. Its earnings per share(EPS) is $ 1.46 and its beta value stands at 1.30 points and has total market capitalization of $ 1.64B and a total of 102.18M outstanding shares.

Alder Biopharmaceuticals Inc(NASDAQ:ALDR) a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, declared that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide (CGRP) antibody for the prevention of frequent episodic migraine, were presented recently by Jeffrey T.L. Smith, M.D., FRCP, Senior Vice President, Translational Medicine at Alder, in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain.

Alder Biopharmaceuticals Inc(NASDAQ:ALDR) reported the surge of 4.73% and closed at $ 49.82 , with the total traded volume of 1.72M shares and opening price was $ 47.72. During last trade its minimum price was $ 47.61 and it gained its highest price of $ 51.43 and has a total of 37.96M outstanding shares and its total market capitalization is $ 1.81B.

Ocwen Financial Corp(NYSE:OCN) NAACP Florida State Conference declared the second in a series of local homeowner outreach events held in partnership with Ocwen Financial Corporation (OCN), a leading financial services holding company. The Assist & Hope for Homeowners event, planned for Saturday, June 20, will provide Florida homeowners with opportunities to learn about loan modification programs, counting principal reduction, which can assist make their homes more affordable.

Following a very successful series debut in Chicago, the event will bring Ocwen customers together with United States Department of Housing and Urban Development (HUD) approved financial counselors and Ocwen Home Retention Agents, who can explore with homeowners potential loan modification options.

In Florida specifically, the situation is dire. According to data collected by RealtyTrac, just this past April, one out of every 425 Florida housing units was in foreclosure. In 2014, the state had the highest foreclosure rate in the country.

Ocwen Financial Corp(NYSE:OCN) reported the surge of 0.47 %, after closing price for the day was $10.76 and opening at the price of $10.64. Its total trading volume for the day was 1.69M  shares, versus its average volume of 2.80M shares. Its earnings per share are $-3.99.